KEROS THERAPEUTICS, INC. (KROS) Operating income 2019–2025
KEROS THERAPEUTICS, INC. (KROS) annual operating income history from SEC filings — each fiscal year as reported.
$67.6MFY2025 · since FY2019: -$10.6M → $67.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $67.6M | +132.0% |
| FY2024 | -$210.8M | -24.1% |
| FY2023 | -$169.9M | -48.0% |
| FY2022 | -$114.8M | -103.6% |
| FY2021 | -$56.4M | -20.8% |
| FY2020 | -$46.7M | -341.7% |
| FY2019 | -$10.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice